Bendamustine is safe and effective for lymphodepletion before tisagenlecleucel in patients with refractory or relapsed large B-cell lymphomas.

Saved in:
Bibliographic Details
Title: Bendamustine is safe and effective for lymphodepletion before tisagenlecleucel in patients with refractory or relapsed large B-cell lymphomas.
Authors: Ghilardi, G.1,2,3 (AUTHOR), Chong, E.A.1,2,3 (AUTHOR), Svoboda, J.1,2,3 (AUTHOR), Wohlfarth, P.4 (AUTHOR), Nasta, S.D.1,3 (AUTHOR), Williamson, S.5 (AUTHOR), Landsburg, J.D.1,3 (AUTHOR), Gerson, J.N.1,3 (AUTHOR), Barta, S.K.1,2,3 (AUTHOR), Pajarillo, R.1,2,3 (AUTHOR), Myers, J.5 (AUTHOR), Chen, A.I.5 (AUTHOR), Schachter, L.5 (AUTHOR), Yelton, R.1,2 (AUTHOR), Ballard, H.J.1,3 (AUTHOR), Hodges Dwinal, A.5 (AUTHOR), Gier, S.2,3 (AUTHOR), Victoriano, D.2,3 (AUTHOR), Weber, E.1,3 (AUTHOR), Napier, E.1,3 (AUTHOR)
Source: Annals of Oncology. Sep2022, Vol. 33 Issue 9, p916-928. 13p.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1016/j.annonc.2022.05.521